Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120

Although the HVTN 505 DNA/recombinant adenovirus type 5 vector HIV-1 vaccine trial showed no overall efficacy, analysis of breakthrough HIV-1 sequences in participants can help determine whether vaccine-induced immune responses impacted viruses that caused infection. We analyzed 480 HIV-1 genomes sa...

Descripción completa

Detalles Bibliográficos
Autores principales: deCamp, Allan C., Rolland, Morgane, Edlefsen, Paul T., Sanders-Buell, Eric, Hall, Breana, Magaret, Craig A., Fiore-Gartland, Andrew J., Juraska, Michal, Carpp, Lindsay N., Karuna, Shelly T., Bose, Meera, LePore, Steven, Miller, Shana, O'Sullivan, Annemarie, Poltavee, Kultida, Bai, Hongjun, Dommaraju, Kalpana, Zhao, Hong, Wong, Kim, Chen, Lennie, Ahmed, Hasan, Goodman, Derrick, Tay, Matthew Z., Gottardo, Raphael, Koup, Richard A., Bailer, Robert, Mascola, John R., Graham, Barney S., Roederer, Mario, O’Connell, Robert J., Michael, Nelson L., Robb, Merlin L., Adams, Elizabeth, D’Souza, Patricia, Kublin, James, Corey, Lawrence, Geraghty, Daniel E., Frahm, Nicole, Tomaras, Georgia D., McElrath, M. Juliana, Frenkel, Lisa, Styrchak, Sheila, Tovanabutra, Sodsai, Sobieszczyk, Magdalena E., Hammer, Scott M., Kim, Jerome H., Mullins, James I., Gilbert, Peter B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693417/
https://www.ncbi.nlm.nih.gov/pubmed/29149197
http://dx.doi.org/10.1371/journal.pone.0185959

Ejemplares similares

Ejemplares similares